United States
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
42.08%
|
Sept. 30, 2024 | USD 171.94 | 0.61% |
|
United States |
|
2 |
32.62%
|
Sept. 30, 2024 | USD 469.04 | 11.13% |
|
United States |
|
3 |
31.25%
|
Sept. 30, 2024 | USD 11.72 | -2.58% |
|
United States |
|
4 |
28.05%
|
Sept. 30, 2024 | USD 2.10 | -10.47% |
|
United States |
|
5 |
26.16%
|
Sept. 30, 2024 | USD 87.03 | 0.38% |
|
United States |
|
6 |
24.39%
|
Sept. 28, 2024 | USD 161.62 | -1.91% |
|
United States |
|
7 |
23.85%
|
Sept. 30, 2024 | USD 160.89 | 0.58% |
|
United States |
|
8 |
18.33%
|
Oct. 31, 2024 | USD 105.88 | -0.95% |
|
United States |
|
9 |
17.51%
|
Oct. 31, 2024 | USD 41.97 | -0.12% |
|
United States |
|
10 |
16.38%
|
Sept. 30, 2024 | USD 134.73 | -1.25% |
|
United States |
|
11 |
15.99%
|
Dec. 31, 2024 | USD 106.43 | 0.86% |
|
United States |
|
12 |
14.24%
|
Sept. 28, 2024 | USD 36.33 | -3.02% |
|
United States |
|
13 |
14.18%
|
Oct. 31, 2024 | USD 41.32 | -0.96% |
|
United States |
|
14 |
12.86%
|
Dec. 28, 2024 | USD 54.58 | 0.40% |
|
United States |
|
15 |
12.62%
|
Sept. 29, 2024 | USD 39.88 | -9.12% |
|
United States |
|
16 |
11.43%
|
Sept. 30, 2024 | USD 159.20 | -0.47% |
|
United States |
|
17 |
10.20%
|
Sept. 30, 2024 | USD 21.69 | -0.55% |
|
United States |
|
18 |
9.20%
|
Sept. 30, 2024 | USD 5.30 | -2.93% |
|
United States |
|
19 |
9.17%
|
Sept. 28, 2024 | USD 36.31 | -0.49% |
|
United States |
|
20 |
8.06%
|
Sept. 30, 2024 | USD 30.69 | -0.74% |
|
United States |
|
21 |
5.75%
|
Sept. 30, 2024 | USD 57.74 | 2.21% |
|
United States |
|
22 |
5.22%
|
Oct. 26, 2024 | USD 30.98 | 0.10% |
|
United States |
|
23 |
4.91%
|
Sept. 30, 2024 | USD 21.63 | 2.22% |
|
United States |
|
24 |
4.28%
|
Sept. 30, 2024 | USD 50.02 | -2.36% |
|
United States |
|
25 |
3.25%
|
Nov. 2, 2024 | USD 3.29 | -3.80% |
|
United States |
|
26 |
2.36%
|
Oct. 27, 2024 | USD 38.14 | -2.15% |
|
United States |
|
27 |
2.09%
|
Sept. 30, 2024 | USD 4.81 | 1.05% |
|
United States |
|
28 |
1.93%
|
Sept. 30, 2024 | USD 5.49 | -2.49% |
|
United States |
|
29 |
1.36%
|
Sept. 30, 2024 | USD 46.95 | -1.03% |
|
United States |
|
30 |
1.13%
|
Sept. 30, 2024 | USD 254.43 | 0.09% |
|
United States |
|
31 |
-3.50%
|
Sept. 30, 2024 | USD 1.86 | -0.53% |
|
United States |
|
32 |
-5.24%
|
Sept. 30, 2024 | USD 4.23 | -1.40% |
|
United States |
|
33 |
-10.62%
|
Sept. 30, 2024 | USD 7.69 | 3.78% |
|
United States |
|
34 |
-16.72%
|
June 30, 2024 | USD 1.50 | -1.32% |
|
United States |
|
35 |
-21.07%
|
Sept. 30, 2024 | USD 5.29 | -1.31% |
|
United States |
|
36 |
-53.75%
|
Sept. 30, 2024 | NA | NA |
|
United States |
|
37 |
-144.61%
|
Sept. 30, 2024 | USD 20.22 | -1.17% |
|
United States |
|
38 |
-211.54%
|
Sept. 30, 2024 | USD 59.41 | -0.03% |
|
United States |
|
39 |
-223.50%
|
Sept. 30, 2024 | USD 77.88 | 1.70% |
|
United States |
|
40 |
-647.89%
|
Sept. 30, 2024 | USD 325.47 | -2.79% |
|
United States |
|
41 |
-5,182.00%
|
Sept. 30, 2023 | USD 1.31 | -3.68% |
|
United States |
|
42 |
-5,519.81%
|
Dec. 31, 2023 | USD 38.79 | -3.75% |
|
United States |
|
43 |
-5,912.20%
|
Sept. 30, 2024 | USD 5.03 | -4.37% |
|
United States |
|
44 |
-7,517.40%
|
Sept. 30, 2024 | USD 4.37 | -2.02% |
|
United States |
|
45 |
-9,648.10%
|
Sept. 30, 2024 | USD 1.43 | -3.38% |
|
United States |
|
46 |
-54,815.00%
|
Sept. 30, 2024 | USD 1.09 | -4.39% |
|
United States |
|
47 |
-81,990.14%
|
Sept. 30, 2024 | USD 53.85 | -0.43% |
|
United States |
|
48 |
-119,507.69%
|
Sept. 30, 2024 | USD 9.29 | -3.23% |
|
United States |
The Pet Food company in United States with the highest EBITDA Margin is Zoetis Inc. (NYSE: ZTS) at 42.08%.
The Pet Food company in United States with the lowest EBITDA Margin is 89bio, Inc. (NasdaqGM: ETNB) at -119,507.69%.
The top 10 Pet Food companies in United States by EBITDA Margin are Zoetis Inc., IDEXX Laboratories, Inc., Elanco Animal Health Incorporated, Ironwood Pharmaceuticals, Inc., Colgate-Palmolive Company, Charles River Laboratories International, Inc., Balchem Corporation, The J. M. Smucker Company, Oil-Dri Corporation of America and Ingredion Incorporated.
The bottom 10 Pet Food companies in United States by EBITDA Margin are 89bio, Inc., Akero Therapeutics, Inc., AN2 Therapeutics, Inc., Ikena Oncology, Inc., Terns Pharmaceuticals, Inc., Third Harmonic Bio, Inc., Crinetics Pharmaceuticals, Inc., Palisade Bio, Inc., Madrigal Pharmaceuticals, Inc. and Insmed Incorporated.